Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Korean Elderly People
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0001963
- Lead Sponsor
- Ewha Womans University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Eligible individuals were ambulatory adults aged =65 yearswho never received the pneumococcal vaccine and in whom underlying chronic illnesses such as hypertension and diabetes mellituswere stable.
Exclusion criteria were immune compromising conditions such as HIV infection, leukemia, lymphoma, Hodgkin’sdisease, multiple myeloma, generalized malignancy, chronic renalfailure or nephrotic syndromes, congenital or acquired immunode-ficiencies, diseases requiring treatment using immunosuppressivedrugs, including long-term systemic corticosteroids or radiationtherapy, solid organ transplantation, functional or anatomic asplenia, cerebrospinal fluid leaks or cochlear implants, a history of hypersensitivity to vaccine or invasive pneumococcal diseases, any coagulation disorder, and a history of antibiotic use within one week.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method